Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor-Reference-Cited by-同舟云学术

Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor

Published:2018-04 Issue:2 Volume:11 Page:193-204
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Montelius Mikael,Spetz Johan,Jalnefjord Oscar,Berger Evelin,Nilsson Ola,Ljungberg Maria,Forssell-Aronsson Eva

Funder

Swedish Research Council

Swedish Cancer Society

BioCARE—a National Strategic Research Program at the University of Gothenburg

King Gustav V Jubilee Clinic Cancer Research Foundation

Sahlgrenska University Hospital Research Funds

Assar Gabrielsson Cancer Research Foundation

Adlerbertska Research Fund

Wilhelm and Martina Lundgren science trust fund

Royal Society of Arts and Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Introduction to radiobiology of targeted radionuclide therapy;Pouget;Front Med,2015

2. Current concepts in clinical radiation oncology;Orth;Radiat Environ Biophys,2014

3. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

4. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives;Marcus;Crit Rev Oncol Hematol,2009

5. Assessing tumor response to therapy;Weber;J Nucl Med,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Contrast-Enhanced MRI in the Abdomen of Mice with High Temporal and Spatial Resolution Using Stack-of-Stars Sampling and KWIC Reconstruction;Tomography;2022-08-24

2. Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management;European Journal of Nuclear Medicine and Molecular Imaging;2021-04-26

3. Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward;Current Topics in Medicinal Chemistry;2020-12-03

4. Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy;The Lancet Oncology;2020-09

5. Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer;PLOS ONE;2019-11-14